This report includes information about branchiootorenal syndrome 1 (BOR1), which is one of several related autosomal dominant diseases associated with the human gene EYA1; see the human disease model report for 'branchiootorenal spectrum disorders, EYA1-related' (see FBhh0000463).
Variant(s) implicated in human disease tested (as analogous mutation in fly gene): G594S in the fly eya gene [corresponds to G393S (G426S) in the human EYA1 gene]; S655P in the fly eya gene [corresponds to S454P (S487P) in the human EYA1 gene]; L673R in the fly eya gene [corresponds to L472R (L505R) in the human EYA1 gene].
[updated Jul. 2017 by FlyBase; FBrf0222196]
[BRANCHIOOTORENAL SYNDROME 1; BOR1](https://omim.org/entry/113650)
[EYA TRANSCRIPTIONAL COACTIVATOR AND PHOSPHATASE 1; EYA1](https://omim.org/entry/601653)
Branchiootorenal syndrome BOR) is characterized by sensorineural, conductive, or mixed hearing loss, structural defects of the outer, middle, and inner ear, branchial fistulas or cysts, and renal abnormalities ranging from mild hypoplasia to complete absence. Reduced penetrance and variable expressivity are observed (Fraser et al., 1978; pubmed:263442). [from MIM:113650; 2017.01.06]
Branchiootorenal syndrome 1 (BOR1) is caused by heterozygous mutation in the EYA1 gene (autosomal dominant). [from MIM:113650; 2017.01.06]
Many to one: 4 human to 1 Drosophila; the other human genes are EYA2, EYA3, and EYA4.
Moderate- to high-scoring ortholog of human EYA1, EYA2, EYA3, and EYA4 (1 Drosophila to 4 human). Dmel\eya shares 39-45% identity and 51-58% similarity with the human genes.